Detalles de la búsqueda
1.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Lancet HIV
; 11(2): e75-e85, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38141637
Resultados
1 -
1
de 1
1
Próxima >
>>